Plan for Testing Fingerstick Bloods on Magellan Systems

Status unconfirmed

Conditions studied: Lead Poisoning

In brief

This study is to supplement our internal data that demonstrates the continued performance of capillary blood samples on Magellan's lead testing systems: LeadCare II, LeadCare Ultra (which have been cleared previously by FDA), and PediaStat, which is an upgraded LeadCare II instrument in development.

Key facts

Study ID

NCT03256383

Run by

Magellan Diagnostics

People needed

190

Starts

2017-07-31

Expected to finish

2017-08-31

Last updated by the study team

2017-08-22

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy subjects who consent to a capillary blood collection

You may not qualify if…

• Patients are not currently taking chelating agents, e.g., penicillamine, succimer

Where it is running

• Pediatric Associates, Inc. — Brockton, Massachusetts, United States (enrolling)
• Pediatrics Associates, Inc — Hanson, Massachusetts, United States (enrolling)
• Pediatrics Associates, Inc — West Bridgewater, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.